Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Comment by RazeKreationson Jan 08, 2022 6:55pm
214 Views
Post# 34296821

RE:RE:Kinlytic?

RE:RE:Kinlytic?
That is true that there are no longer any patents on urokinase (kinlytic). All patents expired in the 1990's. And are no longer accepted. The goal is for competition to the one supplier there is now. Microbix made and supplied Kinlytic in the past using their own facilities but that is no longer allowed. It has to be manufactured in a separate facility to avoid any contamination from viruses etc. Then that facility has to certified and several production runs made to prove consistent quality. Microbix did not have the deep pockets to go alone on the project, that why a partnership is sought. When Kinlytic was on the market, it was the preferred drug of choice. It was proven safe and effective. The market for urokinase in the United States alone is well north of 1Billion dollars per year. Even a 10% share of that would be pretty attainable.
<< Previous
Bullboard Posts
Next >>